NCT06600568View on ClinicalTrials.gov

Novel Therapeutic Approach for Human T-cell Malignancies

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2026

Conditions
T-Cell Leukemia/Lymphoma, Adult
Interventions
OTHER

Translation analysis

Novel strategies to selectively eliminate neoplastic T cells by modulating intracellular ROS levels.

Trial Locations (2)

35128

RECRUITING

Istituto Oncologico Veneto, Padua

80100

RECRUITING

Istituto Nazionale Tumori Fondazione G.Pascale, Napoli

All Listed Sponsors
collaborator

Istituto Nazionale Tumori IRCSS-Fondazione G.Pascale

UNKNOWN

lead

Istituto Oncologico Veneto IRCCS

OTHER